These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16139438)

  • 1. The potential utility of statins as novel weapons against graft-versus-host disease.
    Namazi MR; Handjani F; Sodaifi M
    Med Hypotheses; 2005; 65(6):1203-4. PubMed ID: 16139438
    [No Abstract]   [Full Text] [Related]  

  • 2. [Graft-versus-host disease].
    Svedentsov EP; Sharygin SL; Epifanov NS; Matveev GA
    Klin Med (Mosk); 1993; 71(5):19-23. PubMed ID: 8301977
    [No Abstract]   [Full Text] [Related]  

  • 3. Graft-versus-host disease: suppression by statins.
    Broady R; Levings MK
    Nat Med; 2008 Nov; 14(11):1155-6. PubMed ID: 18989280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow transplantation and graft-versus-host disease.
    Powles RL
    Curr Opin Immunol; 1989-1990; 2(6):870-5. PubMed ID: 2486567
    [No Abstract]   [Full Text] [Related]  

  • 5. Bone marrow augmentation of kidney allografts can cause graft-versus-host disease in immunosuppressed recipients.
    Pirenne J; Moon C; Gruessner A; Benedetti E; Nakhleh RE; Uckun F; Gruessner RW
    Transplant Proc; 1996 Apr; 28(2):941-2. PubMed ID: 8623472
    [No Abstract]   [Full Text] [Related]  

  • 6. Is there an effective therapy for chronic graft-versus-host disease?
    Schiller G; Gale RP
    Bone Marrow Transplant; 1993 Mar; 11(3):189-92. PubMed ID: 8467281
    [No Abstract]   [Full Text] [Related]  

  • 7. Pleiotropic approach to graft-versus-host disease.
    El-Jawahri A; Chen YB
    J Clin Oncol; 2013 Dec; 31(35):4462-4. PubMed ID: 24166516
    [No Abstract]   [Full Text] [Related]  

  • 8. Syngeneic graft-versus-host disease: a report of two cases and literature review.
    Latif T; Pohlman B; Kalaycio M; Sobecks R; Hsi ED; Andresen S; Bolwell BJ
    Bone Marrow Transplant; 2003 Sep; 32(5):535-9. PubMed ID: 12942102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Allogenic bone marrow transplantation complications. Part II].
    Saloua L; Tarek BO; Abderrahman A; Abdeladhim BA
    Tunis Med; 2000 Mar; 78(3):152-7. PubMed ID: 11026816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in GVHD: novel lymphocyte subsets and cytokine dysregulation.
    Ferrara JL
    Bone Marrow Transplant; 1992; 10 Suppl 1():10-2. PubMed ID: 1387830
    [No Abstract]   [Full Text] [Related]  

  • 11. Preventing graft-versus-host disease: transplanters glimpse hope beyond immunosuppressants.
    McNeil C
    J Natl Cancer Inst; 2013 Jul; 105(13):922-3. PubMed ID: 23781000
    [No Abstract]   [Full Text] [Related]  

  • 12. Graft-versus-host disease.
    Kodo H
    Nihon Ketsueki Gakkai Zasshi; 1987 Dec; 50(8):1621-6. PubMed ID: 2833846
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunosuppressive agents.
    Dannie E
    Nurs Times; 1993 Jan 27-Feb 2; 89(4):34-7. PubMed ID: 8437902
    [No Abstract]   [Full Text] [Related]  

  • 14. Bone marrow transplantation: new approaches to immunosuppression and management of acute graft-versus-host disease.
    Auletta JJ; Cooke KR
    Curr Opin Pediatr; 2009 Feb; 21(1):30-8. PubMed ID: 19242239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Titrating graft-versus-host disease: is it worth a try?
    Akpek G
    Bone Marrow Transplant; 2006 Nov; 38(10):653-6. PubMed ID: 17006455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft-versus-host disease.
    Nijhawan A; Drolet BA
    Adv Dermatol; 2001; 17():115-39. PubMed ID: 11758114
    [No Abstract]   [Full Text] [Related]  

  • 17. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
    Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pemphigoid-like ocular lesions in patients with graft-versus-host disease following allogeneic bone marrow transplantation.
    Karwacka E; Ołdakowska-Jedynak U; Brydak-Godowska J; Paczek L; Kecik D
    Transplant Proc; 2006; 38(1):292-4. PubMed ID: 16504728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention and treatment of graft-versus-host disease].
    Wiktor-Jedrzejczak W
    Acta Haematol Pol; 1987; 18(3-4):220-4. PubMed ID: 3330400
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunological response in vitro by Candida after allogeneic bone marrow transplantation.
    Tollemar J; Sundberg B; Markling L; Ringdén O
    Bone Marrow Transplant; 1991; 7 Suppl 2():48. PubMed ID: 1878714
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.